OnKure Therapeutics' CFO and CEO sell shares at $2.97 on December 22, 2025.

martes, 23 de diciembre de 2025, 8:15 pm ET1 min de lectura
OKUR--

OnKure Therapeutics, Inc. (OKUR) recently disclosed that Chief Financial Officer Leverone Jason A. has sold 302 shares at a price of $2.97 per share on December 22, 2025. Additionally, Director, President, and CEO Saccomano Nicholas A has also sold 87 shares at the same price on the same date.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios